DEFEND Study
DEFEND stands for DExtrose gel versus Formula as sEcoNdary treatment for neonatal hypoglycaemia.
The DEFEND Study aims to find out which treatment is better for newborn babies whose blood sugar remains low after their first treatment with dextrose gel and a feed.
About the DEFEND Study
Some newborn babies develop low blood sugar, also called neonatal hypoglycaemia. Babies who are at higher risk have their blood sugar checked after birth.
If a baby's blood sugar is low, the first treatment is usually dextrose gel together with a feed. The baby's blood sugar is then checked again 30–60 minutes later.
For some babies, the blood sugar is still low. We do not yet know which treatment is better to give next. DEFEND compares two treatments already used in routine care:
Repeat dextrose gel + feed – a second dose of dextrose gel, followed by breastfeeding or breast milk feeding.
OR
Infant formula – a single formula feed given as treatment for the low blood sugar.
This short video explains low blood sugar in newborn babies, how it is checked and treated, and what taking part in the DEFEND Study may involve.
Why is this study important?
Both repeat dextrose gel and infant formula are used when a baby's blood sugar remains low after initial treatment. However, we do not know which is the better second treatment.
The DEFEND Study will help us understand which treatment is more effective and how these treatments affect babies and feeding.
Who can take part?
Babies born at Auckland City Hospital who develop low blood sugar and whose blood sugar remains low after their first treatment may be eligible for the DEFEND Study.
If your baby becomes eligible, the study team will explain the study, answer your questions and give you the full Participant Information Sheet before asking for written consent.
You do not need to make any decision before your baby is born.
What does the study involve?
If you choose for your baby to take part, your baby will be randomly allocated to receive either:
- a second dose of dextrose gel followed by breastfeeding or breast milk feeding;
OR
- a single formula feed.
We will also collect information about your pregnancy, your baby's birth and your baby's care.
Your baby's usual care will not be affected by whether or not you choose to take part.
How can I find out more?
Talk with your midwife, doctor or a member of the DEFEND Study team.
Email: DEFEND@auckland.ac.nz
The study has been approved by the Northern B Health and Disability Ethics Committee (reference: 2026 FULL 26240).
The DEFEND Study is supported by the Auckland Medical Research Foundation (AMRF).